A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.
Clinical trial NCT03170271 · COMPLETED
Trial details
- NCT number
- NCT03170271
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2019-09-25
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.